Polycystic ovarian syndrome

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase II: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Fundacio Sant Joan De Deu Academic
    METFORMIN, PIOGLITAZONE, SPIRONOLACTONE; PIOGLITAZONE; PIOGLITAZONE, SPIRONOLACTONE
    2024-518527-29-00 5 countries 2022 n=316
    Ended

Phase I

1 trial
  • Centre Hospitalier Universitaire De Nantes Academic
    IMP not specified
    2024-514102-32-00 1 country 2024 n=20
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Centre Hospitalier Universitaire De Nantes Academic 1 Phase I 0
Fundacio Sant Joan De Deu Academic 1 Phase II 0
New trials by year
2022
1
2024
1
← All indication landscapes